TRAF6 and intracranial hemorrhage: It has been found that blocking TRAF6 limits the inflammatory response-mediated by intracranial hemorrhage (Yang et al., 2020), Alzheimer’s disease (Wang et al., 2018), and Salmonella typhimurium infection (Min et al., 2017).